$0The market capitalization is the market value of the company. It is the sum of the value of all outstanding shares.
$0.00 - $0.00The lowest and highst price in the last 52 weeks.
0.0xThe price-earnings ratio is the ratio between the price per share (stock price) and the earnings per share. It indicates the percentage of the price per share (stock price) that is generated in earnings in the last 12 months.
$0.00 (0.0%)Dividends per share is the amount of dividends paid out to the shareholder of a single share in the last 12 months. The percentage indicates the ratio of the company's annual dividend compared to its current price per share (stock price).
|Enterprise Value||-$937 Million|
|Dividend Yield||$0.00 (0.0%)|
|1 Year Return||0.0%|
|Outstanding Shares||221 Million|
|Avg 30 Day Volume||0|
|Earnings per Share||$3.07|
|Price to Sales Ratio||6.52|
|Price to Book Ratio||3.26|
|Revenue to Enterprise Value||-0.15|
|EBIT to Enterprise Value||-0.32|
|Total Debt to Enterprise Value||-2.7|
|Debt to Equity||0.2|
|Gross Profit||$5.69 Billion|
|Net Income||$682 Million|
|Quarterly Earnings Growth (YoY)||+14.1%|
|Return on Equity||5.49%|
|Return on Assets||3.66%|
|Return on Invested Capital||17.11%|
CEO: Leonard Bell
Industry: Pharmaceutical Preparation Manufacturing
No summary available.Seeking Alpha, 3 months ago
21 July 2021 13:45 BST NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN View post on CompanyNewsHQ : Acquisition of Alexion completedCompanyNewsHQ, 3 months ago
Related Stocks: ALXN ,GuruFocus, 3 months ago